Part 3 of the 20/20 investigation examines the rise in U.S. “Canadian Drug” strip stores that fill local prescription with imported medications at a lower price. According to the FDA, this is illegal, as the 90 day import exemption only applies to new potentially lifesaving therapies that are not approved in the U.S. Furthermore, the practice may be risky. During the 20/20 investigation four drugs were ordered in four different stores. The producers ultimately received each order. Two contained significant impurities according to laboratory analysis. The third drug was expired. The fourth drug was from Turkey, and was of unknown legitimacy. In spite of all four operations advertising Canadian drugs, not a single item was actually shipped from, originated from, or ever touched soil in, Canada.
About the Author: William Llewellyn
William Llewellyn is a researcher in the field of human performance enhancement. He is also author of the bestselling ANABOLICS book series, most recently the ANABOLICS 10th Edition. William is an active supporter of the harm reduction community, and currently serves as honorary lecturer at the Centre for Public Health at Liverpool John Moores University.